Form 8-K - Current report:
SEC Accession No. 0001558370-25-009000
Filing Date
2025-06-30
Accepted
2025-06-30 16:05:12
Documents
13
Period of Report
2025-06-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mtva-20250630x8k.htm   iXBRL 8-K 78314
2 GRAPHIC mtva-20250630x8k001.jpg GRAPHIC 9107
  Complete submission text file 0001558370-25-009000.txt   218019

Data Files

Seq Description Document Type Size
3 EX-101.SCH mtva-20250630.xsd EX-101.SCH 3450
4 EX-101.LAB mtva-20250630_lab.xml EX-101.LAB 15927
5 EX-101.PRE mtva-20250630_pre.xml EX-101.PRE 10054
15 EXTRACTED XBRL INSTANCE DOCUMENT mtva-20250630x8k_htm.xml XML 4854
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 251091994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)